Analysis of Glioblastoma’s Peritumoral Brain Zone - Developing of Per-operative Analysis and New Therapeutic Targets

Jean-Michel Lemée, Anne Clavreul, Philippe Menei


GB is the most frequent and aggressive primary tumor of the central nervous system. The mechanisms of recurrence remain unclear but the infiltration of the peritumoral brain zone by GB cells may be considered as the explanation of the high rate of local recurrences. A better understanding of the characteristics of the PBZ is critical to understand the mechanisms of GB recurrence, optimize the quality of the surgical resection and develop new therapies. During the first part of my PhD, we studied the heterogeneity of the glioblastoma’s peritumoral brain zone (GB-PBZ) using the different techniques used routinely to analyze tumor samples, identifying several alterations specific to the GB-PBZ. Also, we solved a methodological problem with the definition of the best control for brain tumor proteomic analysis. The second part of my PhD will be focused on the development of per-operative analysis of the GB-PBZ to guide the surgical resection of the tumor, and the molecular analysis of the GB-PBZ to develop new therapeutic targets for GB treatment. First, we decided to study two modern techniques of microscopy: the Second Harmonic Imaging Microscopy and the Two Photons-Excited Fluorescence to allow a fast and reproducible per-operative analysis of the GB-PBZ with the aim to optimize the complete resection of the tumor. After the validation of the proteins found in the multimodal analysis of the GB-PBZ, we will assess the expression of these proteins in a cohort of patients from the national clinico-biological collection of GB to assess if these biomarkers can be used as therapeutic targets or as target for vectorized nanotherapies.


  1. Chaichana KL, Jusue-Torres I, Navarro-Ramirez R, Raza SM, Pascual-Gallego M, Ibrahim A, HernandezHermann M, Gomez L, Ye X, Weingart JD, Olivi A, Blakeley J, Gallia GL, Lim M, Brem H, QuinonesHinojosa A. Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma. Neuro Oncol. 2013 Nov 26. [Epub ahead of print]
  2. Clavreul A, Etcheverry A, Chassevent A, Quillien V, Avril T, Jourdan ML, Michalak S, François P, Carré JL, Mosser J; Grand Ouest Glioma Project Network, Menei P. Isolation of a new cell population in the glioblastoma microenvironment. J Neurooncol. 2012 Feb;106(3):493-504.
  3. Glas M, Rath BH, Simon M, Reinartz R, Schramme A, Trageser D, Eisenreich R, Leinhaas A, Keller M, Schildhaus HU, Garbe S, Steinfarz B, Pietsch T, Steindler DA, Schramm J, Herrlinger U, Brüstle O, Scheffler B. Residual tumor cells are unique cellular targets in glioblastoma. Ann Neurol. 2010 Aug;68(2):264-9.
  4. Lemée JM, Com E, Clavreul A, Avril T, Quillien V, de Tayrac M, Pineau C, Menei P. Proteomic analysis of glioblastomas: what is the best brain control sample? J Proteomics. 2013 Jun 24;85:165-73.
  5. Nagashima G, Suzuki R, Hokaku H, Takahashi M, Miyo T, Asai J, Nakagawa N, Fujimoto T. Graphic analysis of microscopic tumor cell infiltration, proliferative potential, and vascular endothelial growth factor expression in an autopsy brain with glioblastoma. Surg Neurol. 1999 Mar;51(3):292-9.
  6. Petrecca K, Guiot MC, Panet-Raymond V, Souhami L. Failure pattern following complete resection plus radiotherapy and temozolomide is at the resection margin in patients with glioblastoma. J Neurooncol. 2013 Jan;111(1):19-23.
  7. Sherriff J, Tamangani J, Senthil L, Cruickshank G, Spooner D, Jones B, Brookes C, Sanghera P. Patterns of relapse in glioblastoma multiforme following concomitant chemoradiotherapy with temozolomide. Br J Radiol. 2013 Feb;86(1022):20120414
  8. Yamahara T, Numa Y, Oishi T, Kawaguchi T, Seno T, Asai A, Kawamoto K. Morphological and flow cytometric analysis of cell infiltration in glioblastoma: a comparison of autopsy brain and neuroimaging. Brain Tumor Pathol. 2010 Oct;27(2):81-7.

Paper Citation

in Harvard Style

Lemée J., Clavreul A. and Menei P. (2014). Analysis of Glioblastoma’s Peritumoral Brain Zone - Developing of Per-operative Analysis and New Therapeutic Targets . In Doctoral Consortium - DCBIOSTEC, (BIOSTEC 2014) ISBN Not Available, pages 54-59

in Bibtex Style

author={Jean-Michel Lemée and Anne Clavreul and Philippe Menei},
title={Analysis of Glioblastoma’s Peritumoral Brain Zone - Developing of Per-operative Analysis and New Therapeutic Targets},
booktitle={Doctoral Consortium - DCBIOSTEC, (BIOSTEC 2014)},
isbn={Not Available},

in EndNote Style

JO - Doctoral Consortium - DCBIOSTEC, (BIOSTEC 2014)
TI - Analysis of Glioblastoma’s Peritumoral Brain Zone - Developing of Per-operative Analysis and New Therapeutic Targets
SN - Not Available
AU - Lemée J.
AU - Clavreul A.
AU - Menei P.
PY - 2014
SP - 54
EP - 59
DO -